Tourbillon Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$105M |
| 2 |
Amazon
AMZN
|
+$62.3M |
| 3 |
Broadcom
AVGO
|
+$57.6M |
| 4 |
Tyson Foods
TSN
|
+$56.8M |
| 5 |
MDVN
MEDIVATION, INC.
MDVN
|
+$52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$61.6M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$40.6M |
| 3 |
HP
HPQ
|
+$31.9M |
| 4 |
United Natural Foods
UNFI
|
+$24.6M |
| 5 |
Abercrombie & Fitch
ANF
|
+$23.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.26% |
| 2 | Consumer Discretionary | 9.59% |
| 3 | Technology | 6.55% |
| 4 | Consumer Staples | 5.53% |
| 5 | Communication Services | 3.64% |
Similar funds
Tourbillon Capital Partners's Q4 2014 Portfolio in Review
As of Q4 2014, Tourbillon Capital Partners held 132 positions worth $3.71B, up 35% from $2.74B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Tourbillon Capital Partners deployed $908M of net new capital in Q4 2014, opening 49 new positions and adding to 24 existing holdings. Its largest new stake was Bausch Health: 780,000 shares worth $112M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was AMAG Pharmaceuticals, an estimated $15M trimmed.
- Tourbillon Capital Partners's largest Q4 2014 buy was Bausch Health: 780,000 shares worth $112M.
- Tourbillon Capital Partners added most to Tyson Foods in Q4 2014, an estimated $56.8M increase.
- Tourbillon Capital Partners's biggest Q4 2014 reduction was AMAG Pharmaceuticals, cutting an estimated $15M.
- Tourbillon Capital Partners fully exited NXP Semiconductors in Q4 2014, selling an estimated $61.6M.
- Tourbillon Capital Partners's ten largest holdings make up 38% of its $3.71B portfolio in Q4 2014.
- Tourbillon Capital Partners opened 49 new positions and closed 44 in Q4 2014.
- Tourbillon Capital Partners's portfolio value rose 35% quarter-over-quarter to $3.71B.
Based on Tourbillon Capital Partners's 13F filing for Q4 2014, filed 17 Feb 2015.